Trade Report: The Cantor Fitzgerald Reiterates “$17.00” Price Target for Cross Country Healthcare Inc. (CCRN)

The Cantor Fitzgerald Reiterates “$17.00” Price Target for Cross Country Healthcare Inc. (CCRN)

Cross Country Healthcare Inc. (NASDAQ:CCRN) has been given a $17.00 target price by equities research analysts at Cantor Fitzgerald in a note issued to investors on Wednesday. The brokerage presently has a “buy” rating on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 13.64% from the stock’s previous close.

Several other brokerages have also commented on CCRN. Zacks Investment Research lowered Cross Country Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, October 11th. TheStreet lowered Cross Country Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Finally, BMO Capital Markets restated a “buy” rating and set a $16.00 price target on shares of Cross Country Healthcare in a research note on Friday, August 5th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Cross Country Healthcare currently has an average rating of “Buy” and an average price target of $16.00.

Shares of Cross Country Healthcare (NASDAQ:CCRN) traded up 0.13% during trading on Wednesday, reaching $14.96. The company’s stock had a trading volume of 61,066 shares. The firm’s 50-day moving average is $12.99 and its 200-day moving average is $13.26. Cross Country Healthcare has a 12-month low of $9.72 and a 12-month high of $18.76. The stock’s market capitalization is $493.83 million.

In related news, insider Vickie Anenberg sold 4,800 shares of the firm’s stock in a transaction dated Wednesday, November 16th. The stock was sold at an average price of $15.04, for a total transaction of $72,192.00. Following the sale, the insider now owns 190,717 shares of the company’s stock, valued at $2,868,383.68. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 4.20% of the company’s stock.

Large investors have recently modified their holdings of the stock. US Bancorp DE increased its stake in shares of Cross Country Healthcare by 2.5% in the second quarter. US Bancorp DE now owns 7,491 shares of the company’s stock worth $105,000 after buying an additional 181 shares during the last quarter. Alambic Investment Management L.P. bought a new stake in shares of Cross Country Healthcare during the third quarter worth $132,000. Palo Capital Inc. bought a new stake in shares of Cross Country Healthcare during the third quarter worth $136,000. BNP Paribas Arbitrage SA increased its stake in shares of Cross Country Healthcare by 96.7% in the second quarter. BNP Paribas Arbitrage SA now owns 10,127 shares of the company’s stock worth $141,000 after buying an additional 4,978 shares during the last quarter. Finally, Wealthsource Partners LLC bought a new stake in shares of Cross Country Healthcare during the first quarter worth $145,000. 96.61% of the stock is currently owned by institutional investors.

Cross Country Healthcare Company Profile

Related posts

Leave a Comment